Encision, Inc. Reports Third Quarter Fiscal Year 2017 Results; Sequential Quarterly Revenue Grows 4 Percent Post author:Sam Post published:February 7, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like <b>CROS NT</b> Launches CROScheck At DIA Chicago To Help Clinical Trial Sponsors Meet New ICH GCP E6(R2) Guidelines June 22, 2017 Teva Gains Another $2.48 Billion For Selling The Last Of Its Women???s Health Portfolio September 17, 2017 Bay Area's ChemoCentryx Gets Up to $100M in New Capital Commitments January 3, 2018
<b>CROS NT</b> Launches CROScheck At DIA Chicago To Help Clinical Trial Sponsors Meet New ICH GCP E6(R2) Guidelines June 22, 2017
Teva Gains Another $2.48 Billion For Selling The Last Of Its Women???s Health Portfolio September 17, 2017